Compounds > 5-acetylamino-6-formylamino-3-methyluracil
Page last updated: 2024-09-02

5-acetylamino-6-formylamino-3-methyluracil and warfarin

5-acetylamino-6-formylamino-3-methyluracil has been researched along with warfarin in 1 studies

Compound Research Comparison

Studies
(5-acetylamino-6-formylamino-3-methyluracil)		Trials
(5-acetylamino-6-formylamino-3-methyluracil)		Recent Studies (post-2010)
(5-acetylamino-6-formylamino-3-methyluracil)		Studies
(warfarin)		Trials
(warfarin)		Recent Studies (post-2010) (warfarin)
532536,5732,14314,728

Protein Interaction Comparison

ProteinTaxonomy5-acetylamino-6-formylamino-3-methyluracil (IC50)warfarin (IC50)
Vitamin K epoxide reductase complex subunit 1 Homo sapiens (human)0.0088

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arvela, P; Klebovich, I; Pelkonen, O; Rautio, A; Salonpää, P; Sotaniemi, EA1

Trials

1 trial(s) available for 5-acetylamino-6-formylamino-3-methyluracil and warfarin

ArticleYear
Antipyrine, coumarin and glipizide affect n-acetylation measured by caffeine test.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1995, Volume: 49, Issue:5

    Topics: Acetylation; Adult; Analysis of Variance; Antipyrine; Caffeine; Coumarins; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hypoglycemic Agents; Male; Middle Aged; Uracil; Xanthines

1995